found that GLP-1 receptor agonist use, compared with initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors, was associated with a lower risk of composite MALOs (aHR: 0.84, 95%CI: 0.74-0.94), including specifically lower occurrence of liver decompensation (aHR: 0.83) and all-cause mortality (aHR: 0.84) [56]
On September 29, 2023, the FDA updated its list of bulk drug substances used in compounding pharmacies
Best decision I ever made
Thioredoxin in vascular biology: role in hypertension
Acta Pharm Sinica B 13(5):2291 Faillie JL, Yin H, Yu OH, Herrero A, Altwegg R, Renoux C, Azoulay L (2022) Incretin-Based drugs and risk of intestinal obstruction among patients with type 2 diabetes
The Augustinus Bader cream products also seem to claim to work by triggering endogenous stem cells via a substance called TCF8